stockportfolio.pro
Eli Lilly and Company P/E Ratio 2007–2025
Eli Lilly and Company (LLY) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +12.2%/yr over 18 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 46.67 | -28.4% |
| FY 2024 | 65.22 | -34.0% |
| FY 2023 | 98.78 | +91.4% |
| FY 2022 | 51.60 | +19.1% |
| FY 2021 | 43.33 | +84.3% |
| FY 2020 | 23.52 | +71.6% |
| FY 2019 | 13.71 | -59.1% |
| FY 2018 | 33.52 | — |
| FY 2017 | — | — |
| FY 2016 | 24.57 | -21.5% |
| FY 2015 | 31.30 | +23.7% |
| FY 2014 | 25.29 | +170.7% |
| FY 2013 | 9.34 | -9.1% |
| FY 2012 | 10.28 | +32.4% |
| FY 2011 | 7.76 | +47.0% |
| FY 2010 | 5.28 | -10.8% |
| FY 2009 | 5.92 | — |
| FY 2008 | — | — |
| FY 2007 | — | — |
Source: Eli Lilly and Company SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Eli Lilly and Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeEli Lilly and Company — frequently asked questions
What is Eli Lilly and Company's price-to-earnings ratio?
Eli Lilly and Company (LLY) reported price-to-earnings ratio of 46.67 for fiscal year 2025, per its SEC filings.
How has Eli Lilly and Company's price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, LLY's price-to-earnings ratio grew at roughly 12.2% per year (compound annual rate), from 5.92 to 46.67.
Where does this data come from?
Figures are computed from Eli Lilly and Company's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.